Lee Sherlock, Brendan Martin and Sinah Behsangar founded Meta-Flux in 2020 to help pharma companies detect potential adverse drug reactions early on.
Read more: Meta-Flux: Helping pharma treat lung cancer faster with AI
https://bit.ly/3rphX1y
https://bit.ly/3rphX1y